2clt › Citations

Crystal structure of an active form of human MMP-1.

Figure 1
Figure 2
Figure 3
Iyer S, Visse R, Nagase H, Acharya KR
OpenAccess logo J Mol Biol 362 78-88 (2006)
Cited: 56 times
EuropePMC logo PMID: 16890240

Abstract

The extracellular matrix is a dynamic environment that constantly undergoes remodelling and degradation during vital physiological processes such as angiogenesis, wound healing, and development. Unbalanced extracellular matrix breakdown is associated with many diseases such as arthritis, cancer and fibrosis. Interstitial collagen is degraded by matrix metalloproteinases with collagenolytic activity by MMP-1, MMP-8 and MMP-13, collectively known as the collagenases. Matrix metalloproteinase 1 (MMP-1) plays a pivotal role in degradation of interstitial collagen types I, II, and III. Here, we report the crystal structure of the active form of human MMP-1 at 2.67 A resolution. This is the first MMP-1 structure that is free of inhibitor and a water molecule essential for peptide hydrolysis is observed coordinated with the active site zinc. Comparing this structure with the human proMMP-1 shows significant structural differences, mainly in the relative orientation of the hemopexin domain, between the pro form and active form of the human enzyme.

Reviews - 2clt mentioned but not cited (3)

  1. Interstitial collagen catabolism. Fields GB. J Biol Chem 288 8785-8793 (2013)
  2. Glycosylation of matrix metalloproteases and tissue inhibitors: present state, challenges and opportunities. Boon L, Ugarte-Berzal E, Vandooren J, Opdenakker G. Biochem J 473 1471-1482 (2016)
  3. Biophysical studies of matrix metalloproteinase/triple-helix complexes. Fields GB. Adv Protein Chem Struct Biol 97 37-48 (2014)

Articles - 2clt mentioned but not cited (8)

  1. Metalloproteases meprin α and meprin β are C- and N-procollagen proteinases important for collagen assembly and tensile strength. Broder C, Arnold P, Vadon-Le Goff S, Konerding MA, Bahr K, Müller S, Overall CM, Bond JS, Koudelka T, Tholey A, Hulmes DJ, Moali C, Becker-Pauly C. Proc Natl Acad Sci U S A 110 14219-14224 (2013)
  2. Structural basis for matrix metalloproteinase 1-catalyzed collagenolysis. Bertini I, Fragai M, Luchinat C, Melikian M, Toccafondi M, Lauer JL, Fields GB. J Am Chem Soc 134 2100-2110 (2012)
  3. Crystal structure of an active form of human MMP-1. Iyer S, Visse R, Nagase H, Acharya KR. J Mol Biol 362 78-88 (2006)
  4. Examination of matrix metalloproteinase-1 in solution: a preference for the pre-collagenolysis state. Cerofolini L, Fields GB, Fragai M, Geraldes CFGC, Luchinat C, Parigi G, Ravera E, Svergun DI, Teixeira JMC. J Biol Chem 288 30659-30671 (2013)
  5. Structural studies of the MMP-3 interaction with triple-helical collagen introduce new roles for the enzyme in tissue remodelling. Manka SW, Bihan D, Farndale RW. Sci Rep 9 18785 (2019)
  6. Paralogues of Mmp11 and Timp4 Interact during the Development of the Myotendinous Junction in the Zebrafish Embryo. Matchett EF, Wang S, Crawford BD. J Dev Biol 7 E22 (2019)
  7. The dipeptidyl peptidase IV inhibitors vildagliptin and K-579 inhibit a phospholipase C: a case of promiscuous scaffolds in proteins. Chakraborty S, Rendón-Ramírez A, Ásgeirsson B, Dutta M, Ghosh AS, Oda M, Venkatramani R, Rao BJ, Dandekar AM, Goñi FM. F1000Res 2 286 (2013)
  8. A network pharmacology-based investigation of emodin against pancreatic adenocarcinoma. Shi X, Huang B, Zhu J, Yamaguchi T, Hu A, Tabuchi M, Watanabe D, Yoshikawa S, Mizushima S, Mizushima A, Xia S. Medicine (Baltimore) 102 e33521 (2023)


Reviews citing this publication (7)

  1. Progress in matrix metalloproteinase research. Murphy G, Nagase H. Mol Aspects Med 29 290-308 (2008)
  2. Matrix metalloproteinases in kidney homeostasis and diseases. Tan RJ, Liu Y. Am J Physiol Renal Physiol 302 F1351-61 (2012)
  3. Hemopexin domains as multifunctional liganding modules in matrix metalloproteinases and other proteins. Piccard H, Van den Steen PE, Opdenakker G. J Leukoc Biol 81 870-892 (2007)
  4. Bacterial collagenases - A review. Duarte AS, Correia A, Esteves AC. Crit Rev Microbiol 42 106-126 (2016)
  5. Synthesis and biological applications of collagen-model triple-helical peptides. Fields GB. Org Biomol Chem 8 1237-1258 (2010)
  6. Thymosin beta-4 and the eye: I can see clearly now the pain is gone. Sosne G, Qiu P, Kurpakus-Wheater M. Ann N Y Acad Sci 1112 114-122 (2007)
  7. Matrix Metalloproteinases Inhibitors in Cancer Treatment: An Updated Review (2013-2023). Almutairi S, Kalloush HM, Manoon NA, Bardaweel SK. Molecules 28 5567 (2023)

Articles citing this publication (38)

  1. Structural insights into triple-helical collagen cleavage by matrix metalloproteinase 1. Manka SW, Carafoli F, Visse R, Bihan D, Raynal N, Farndale RW, Murphy G, Enghild JJ, Hohenester E, Nagase H. Proc Natl Acad Sci U S A 109 12461-12466 (2012)
  2. Active site specificity profiling of the matrix metalloproteinase family: Proteomic identification of 4300 cleavage sites by nine MMPs explored with structural and synthetic peptide cleavage analyses. Eckhard U, Huesgen PF, Schilling O, Bellac CL, Butler GS, Cox JH, Dufour A, Goebeler V, Kappelhoff R, Keller UAD, Klein T, Lange PF, Marino G, Morrison CJ, Prudova A, Rodriguez D, Starr AE, Wang Y, Overall CM. Matrix Biol 49 37-60 (2016)
  3. Role of the hemopexin domain of matrix metalloproteinases in cell migration. Dufour A, Sampson NS, Zucker S, Cao J. J Cell Physiol 217 643-651 (2008)
  4. Crystal structures of MMP-9 complexes with five inhibitors: contribution of the flexible Arg424 side-chain to selectivity. Tochowicz A, Maskos K, Huber R, Oltenfreiter R, Dive V, Yiotakis A, Zanda M, Pourmotabbed T, Bode W, Goettig P. J Mol Biol 371 989-1006 (2007)
  5. Mesenchymal stem cells' interaction with skin: wound-healing effect on fibroblast cells and skin tissue. Jeon YK, Jang YH, Yoo DR, Kim SN, Lee SK, Nam MJ. Wound Repair Regen 18 655-661 (2010)
  6. Selective modulation of matrix metalloproteinase 9 (MMP-9) functions via exosite inhibition. Lauer-Fields JL, Whitehead JK, Li S, Hammer RP, Brew K, Fields GB. J Biol Chem 283 20087-20095 (2008)
  7. Structure of collagenase G reveals a chew-and-digest mechanism of bacterial collagenolysis. Eckhard U, Schönauer E, Nüss D, Brandstetter H. Nat Struct Mol Biol 18 1109-1114 (2011)
  8. Identification and structural analysis of type I collagen sites in complex with fibronectin fragments. Erat MC, Slatter DA, Lowe ED, Millard CJ, Farndale RW, Campbell ID, Vakonakis I. Proc Natl Acad Sci U S A 106 4195-4200 (2009)
  9. Mechanical load induces a 100-fold increase in the rate of collagen proteolysis by MMP-1. Adhikari AS, Chai J, Dunn AR. J Am Chem Soc 133 1686-1689 (2011)
  10. Identification of specific hemopexin-like domain residues that facilitate matrix metalloproteinase collagenolytic activity. Lauer-Fields JL, Chalmers MJ, Busby SA, Minond D, Griffin PR, Fields GB. J Biol Chem 284 24017-24024 (2009)
  11. Interdomain flexibility in full-length matrix metalloproteinase-1 (MMP-1). Bertini I, Fragai M, Luchinat C, Melikian M, Mylonas E, Sarti N, Svergun DI. J Biol Chem 284 12821-12828 (2009)
  12. Structural analysis of collagen type I interactions with human fibronectin reveals a cooperative binding mode. Erat MC, Sladek B, Campbell ID, Vakonakis I. J Biol Chem 288 17441-17450 (2013)
  13. Matrix metalloproteinase-1 treatment of muscle fibrosis. Kaar JL, Li Y, Blair HC, Asche G, Koepsel RR, Huard J, Russell AJ. Acta Biomater 4 1411-1420 (2008)
  14. Phage display of tissue inhibitor of metalloproteinases-2 (TIMP-2): identification of selective inhibitors of collagenase-1 (metalloproteinase 1 (MMP-1)). Bahudhanapati H, Zhang Y, Sidhu SS, Brew K. J Biol Chem 286 31761-31770 (2011)
  15. Peptide-based selective inhibitors of matrix metalloproteinase-mediated activities. Ndinguri MW, Bhowmick M, Tokmina-Roszyk D, Robichaud TK, Fields GB. Molecules 17 14230-14248 (2012)
  16. The interface between catalytic and hemopexin domains in matrix metalloproteinase-1 conceals a collagen binding exosite. Arnold LH, Butt LE, Prior SH, Read CM, Fields GB, Pickford AR. J Biol Chem 286 45073-45082 (2011)
  17. Unraveling hidden regulatory sites in structurally homologous metalloproteases. Udi Y, Fragai M, Grossman M, Mitternacht S, Arad-Yellin R, Calderone V, Melikian M, Toccafondi M, Berezovsky IN, Luchinat C, Sagi I. J Mol Biol 425 2330-2346 (2013)
  18. Crystal structure of full-length human collagenase 3 (MMP-13) with peptides in the active site defines exosites in the catalytic domain. Stura EA, Visse R, Cuniasse P, Dive V, Nagase H. FASEB J 27 4395-4405 (2013)
  19. New opportunities in drug design of metalloproteinase inhibitors: combination between structure-function experimental approaches and systems biology. Sela-Passwell N, Trahtenherts A, Krüger A, Sagi I. Expert Opin Drug Discov 6 527-542 (2011)
  20. Crystal structure and functional insights of hemopexin fold protein from grass pea. Gaur V, Qureshi IA, Singh A, Chanana V, Salunke DM. Plant Physiol 152 1842-1850 (2010)
  21. The collagenolytic action of MMP-1 is regulated by the interaction between the catalytic domain and the hinge region. Fasciglione GF, Gioia M, Tsukada H, Liang J, Iundusi R, Tarantino U, Coletta M, Pourmotabbed T, Marini S. J Biol Inorg Chem 17 663-672 (2012)
  22. Ubiquitin-like protein from human placental extract exhibits collagenase activity. De D, Datta Chakraborty P, Mitra J, Sharma K, Mandal S, Das A, Chakrabarti S, Bhattacharyya D. PLoS One 8 e59585 (2013)
  23. A Combination of Soybean and Haematococcus Extract Alleviates Ultraviolet B-Induced Photoaging. Shin J, Kim JE, Pak KJ, Kang JI, Kim TS, Lee SY, Yeo IH, Park JH, Kim JH, Kang NJ, Lee KW. Int J Mol Sci 18 E682 (2017)
  24. Lecture Fell-Muir Lecture: Metalloproteinases: from demolition squad to master regulators. Murphy G. Int J Exp Pathol 91 303-313 (2010)
  25. Computational and In Vitro Investigation of (-)-Epicatechin and Proanthocyanidin B2 as Inhibitors of Human Matrix Metalloproteinase 1. Lee KE, Bharadwaj S, Yadava U, Kang SG. Biomolecules 10 E1379 (2020)
  26. Molecular dynamics simulations of the active matrix metalloproteinase-2: positioning of the N-terminal fragment and binding of a small peptide substrate. Díaz N, Suárez D. Proteins 72 50-61 (2008)
  27. Collagenolytic Matrix Metalloproteinase Activities toward Peptomeric Triple-Helical Substrates. Stawikowski MJ, Stawikowska R, Fields GB. Biochemistry 54 3110-3121 (2015)
  28. The structure of a haemopexin-fold protein from cow pea (Vigna unguiculata) suggests functional diversity of haemopexins in plants. Gaur V, Chanana V, Jain A, Salunke DM. Acta Crystallogr Sect F Struct Biol Cryst Commun 67 193-200 (2011)
  29. Extracellular Matrix Glycoprotein-Derived Synthetic Peptides Differentially Modulate Glioma and Sarcoma Cell Migration. Brösicke N, Sallouh M, Prior LM, Job A, Weberskirch R, Faissner A. Cell Mol Neurobiol 35 741-753 (2015)
  30. Interaction of Selected Terpenoids From Dalbergia sissoo With Catalytic Domain of Matrix Metalloproteinase-1: An In Silico Assessment of Their Anti-wrinkling Potential. Yasmeen S, Gupta P. Bioinform Biol Insights 13 1177932219896538 (2019)
  31. Mutations in the catalytic domain of human matrix metalloproteinase-1 (MMP-1) that allow for regulated activity through the use of Ca2+. Paladini RD, Wei G, Kundu A, Zhao Q, Bookbinder LH, Keller GA, Shepard HM, Frost GI. J Biol Chem 288 6629-6639 (2013)
  32. A synergy between the catalytic and structural Zn(II) ions and the enzyme and substrate dynamics underlies the structure-function relationships of matrix metalloproteinase collagenolysis. Varghese A, Chaturvedi SS, Fields GB, Karabencheva-Christova TG. J Biol Inorg Chem 26 583-597 (2021)
  33. Expression, purification and insights into structure and folding of the ADAM22 pro domain. Sørensen HP, Jacobsen J, Nielbo S, Poulsen FM, Wewer UM. Protein Expr Purif 61 175-183 (2008)
  34. New biochemical insight of conserved water molecules at catalytic and structural Zn2+ ions in human matrix metalloproteinase-I: a study by MD-simulation. Chakrabarti B, Bairagya HR, Mukhopadhyay BP, Sekar K. J Mol Model 23 57 (2017)
  35. Destructive twisting of neutral metalloproteases: the catalysis mechanism of the Dispase autolysis-inducing protein from Streptomyces mobaraensis DSM 40487. Fiebig D, Storka J, Roeder M, Meyners C, Schmelz S, Blankenfeldt W, Scrima A, Kolmar H, Fuchsbauer HL. FEBS J 285 4246-4264 (2018)
  36. Effects of the Nature of the Metal Ion, Protein and Substrate on the Catalytic Center in Matrix Metalloproteinase-1: Insights from Multilevel MD, QM/MM and QM Studies. Varghese A, Chaturvedi SS, DiCastri B, Mehler E, Fields GB, Karabencheva-Christova TG. Chemphyschem 23 (2021)
  37. Structure of Vibrio collagenase VhaC provides insight into the mechanism of bacterial collagenolysis. Wang Y, Wang P, Cao HY, Ding HT, Su HN, Liu SC, Liu G, Zhang X, Li CY, Peng M, Li F, Li S, Chen Y, Chen XL, Zhang YZ. Nat Commun 13 566 (2022)
  38. Association of MMP1 gene polymorphisms with breast cancer risk: A narrative review. Akter T, Aziz MA, Islam MS, Sarwar MS. Health Sci Rep 6 e1607 (2023)


Quick links